QXO (QXO) had the highest return in Q4 2023 by a US stock with a market cap of $2B+, returning 416.9%.
| ASSET | QUARTER | % RETURN |
|---|---|---|
QXO (QXO) | Q4 2023 | 416.92% |
Cytokinetics (CYTK) | Q4 2023 | 184.37% |
Scholar Rock (SRRK) | Q4 2023 | 166.67% |
CleanSpark (CLSK) | Q4 2023 | 164.73% |
Marathon Digital (MARA) | Q4 2023 | 155.33% |
Affirm (AFRM) | Q4 2023 | 132.01% |
Coinbase Global (COIN) | Q4 2023 | 121.41% |
Xometry (XMTR) | Q4 2023 | 111.73% |
TG Therapeutics (TGTX) | Q4 2023 | 102.13% |
Rhythm Pharmaceuticals (RYTM) | Q4 2023 | 100.57% |
Gap (GAP) | Q4 2023 | 98.92% |
Spirit Aerosystems (SPR) | Q4 2023 | 97.76% |
Edgewise Therapeutics (EWTX) | Q4 2023 | 90.92% |
Snap (SNAP) | Q4 2023 | 90.87% |
Aurora Innovation (AUR) | Q4 2023 | 87.55% |
Blueprint Medicines (BPMC) | Q4 2023 | 84.48% |
Kymera Therapeutics (KYMR) | Q4 2023 | 83.83% |
Twist Bioscience (TWST) | Q4 2023 | 83.57% |
Foot Locker (FL) | Q4 2023 | 83.03% |
Iris Energy (IREN) | Q4 2023 | 82.86% |
MicroStrategy (MSTR) | Q4 2023 | 82.25% |
Rocket Companies (RKT) | Q4 2023 | 79.88% |
Compania de Minas Buenaventura SAA ADR (BVN) | Q4 2023 | 79.51% |
Iovance Biotherapeutics (IOVA) | Q4 2023 | 78.68% |
Central Puerto (CEPU) | Q4 2023 | 74.93% |
